Analysis of Risk Factors for Myringosclerosis Formation after Ventilation Tube Insertion

Eung Hyub Kim; Ki Wan Park; Seung Hun Lee; Bong Jik Kim; Yong-Ho Park

doi:10.3346/jkms.2020.35.e83

Journal List > J Korean Med Sci > v.35(13) > 1146278

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kim, Park, Lee, Kim, and Park: Analysis of Risk Factors for Myringosclerosis Formation after Ventilation Tube Insertion

Original Article

Otorhinolaryngology

Journal of Korean Medical Science 2020; 35(13): e83.

Published online: 18 February 2020

DOI: https://doi.org/10.3346/jkms.2020.35.e83

Analysis of Risk Factors for Myringosclerosis Formation after Ventilation Tube Insertion

Eung Hyub Kim^1,^*

, Ki Wan Park^1,^*

, Seung Hun Lee¹

, Bong Jik Kim^1,²

, Yong-Ho Park^1,²

¹Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Korea.

²Brain Research Institute, College of Medicine, Chungnam National University, Daejeon, Korea.

Address for Correspondence: Bong Jik Kim, MD, PhD. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, 282 Munwha-ro, Jung-gu, Daejeon 35015, Republic of Korea. bongjik.kim@cnu.ac.kr

Address for Correspondence: Yong-Ho Park, MD, PhD. Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, 282 Munwha-ro, Jung-gu, Daejeon 35015, Republic of Korea. parkyh@cnu.ac.kr

Equal contributor:

^*Eung Hyub Kim and Ki Wan Park contributed equally to this work.

Received 5 December 2019 Accepted 30 January 2020

The Korean Academy of Medical Sciences

(open-access, https://creativecommons.org/licenses/by-nc/4.0/):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

This study examined possible risk factors for myringosclerosis formation after ventilation tube insertion (VTI).

Methods

A retrospective study was performed in a single tertiary referral center. A total of 582 patients who underwent VTI were enrolled in this study. Patients were divided into two groups based on the presence or absence of myringosclerosis: MS+ and MS−. Characteristics of patients were collected through medical chart review; these included age, gender, nature and duration of effusion, type of ventilation tube (VT), duration and frequency of VTI, incidence of post-VTI infection, incidence of intraoperative bleeding, and presence of postoperative perforation. Incidences of risk factors for myringosclerosis and the severity of myringosclerosis in association with possible risk factors were analyzed.

Results

Myringosclerosis developed in 168 of 582 patients (28.9%) after VTI. Patients in the MS+ group had an older mean age than those in the MS− group. The rates of myringosclerosis were higher in patients with older age, serous otitis media, type 2 VT, post-VTI perforation, and frequent VTI. However, there were no differences in occurrence of myringosclerosis based on gender, duration of effusion, duration of VT placement, incidence of post-VTI infection, or incidence of intraoperative bleeding. The severity of myringosclerosis was associated with the duration of effusion and frequency of VTI.

Conclusion

Older age, serous effusion, type 2 VT, presence of post-VTI perforation, and frequent VTI may be risk factors for myringosclerosis after VTI; the severity of myringosclerosis may vary based on the duration of effusion and frequency of VTI.

Graphical Abstract

Keywords: Otitis Media, Myringosclerosis, Ventilation Tube, Middle Ear, Risk Factor

INTRODUCTION

Tympanosclerosis is associated with sclerotic changes in the tympanic membrane (TM), middle ear cavity, ossicular chain, or (rarely) mastoid cavity; it is characterized by the deposition of degenerated hyaline and calcification of collagen fibrils in the submucosal layer. Tympanosclerosis limited to the TM is known as myringosclerosis,1 and can be defined as a localized tissue reaction involving hyalinization and calcification of the middle fibrous layer of the TM.2 Myringosclerosis is generally asymptomatic, but may cause conductive or mixed type hearing loss if it affects the movement of the TM, ossicular chain, or windows.3

Myringosclerosis is the most common complication after ventilation tube insertion (VTI),4 5 which has been used for the treatment of otitis media with effusion (OME).5 6 The etiology and pathogenesis of this condition have not been fully elucidated; however, VTI, middle ear infection, trauma, genetic tendency, and increased formation of oxygen-derived free radicals have been proposed as risk factors for myringosclerosis.7 Sclerotic changes caused by myringosclerosis could render the TM stiff and inflexible, with fixation of the ossicular chain.8 Therefore, a small myringosclerosis may not affect hearing, while a more extensive plaque may lead to the onset of conductive hearing loss.9 Hearing loss caused by OME itself or myringosclerosis in childhood could result in a detrimental effect on the development of auditory temporal processing, and language development.10

Although VTI is the most common procedure used for the treatment of OME and is presumed to be associated with myringosclerosis, there have only been a few studies of potential risk factors for myringosclerosis after VTI.7 11 This study was performed to investigate possible risk factors for myringosclerosis formation after VTI and to determine factors affecting the severity of myringosclerosis after VTI.

METHODS

Patients

The study population consisted of 582 patients who underwent VTI for OME between January 2011 and March 2016 at Chungnam National University Hospital (Daejeon, Korea). Unilateral VTI was performed in 364 patients, while bilateral VTI was performed in 218 patients. All patients had undergone monthly follow-up for at least 6 months postoperatively. Patients with craniofacial anomalies, such as cleft lip and palate or Treacher-Collins syndrome, as well as those with insufficient medical records or otoscopic images, were excluded from the study. Patients with myringosclerosis before VTI were also excluded. In patients with bilateral VTI, only the left ear was included in the analysis of risk factors, in order to reduce the potential for bias originating from differences in myringosclerosis formation between ears in each patient.

Data collection

Patient data and clinical information were retrospectively collected through medical records review. Patient data collected included the following variables: age; gender; VT type; duration of effusion; characteristics of effusion; duration of VT placement; frequency of VTI; and incidences of intraoperative bleeding, post-VTI infection, and post-VTI perforation; these data were collected from operation records and otoendoscopic imaging. The point of myringosclerosis development was regarded as the date of initial detection after VTI.

Study protocol

Myringosclerosis was divided into five grades according to severity: grade 0, no myringosclerosis; grade 1, myringosclerosis involving a single quadrant of the TM; grade 2, myringosclerosis involving two quadrants of the TM, regardless of the particular quadrants involved; grade 3, myringosclerosis involving three quadrants of the TM; grade 4, myringosclerosis involving all quadrants of the TM (Fig. 1).

Fig. 1

Classification of grade of myringosclerosis based on the number of involved quadrants in the tympanic membrane. (A) Grade 1: one quadrant. (B) Grade 2: two quadrants. (C) Grade 3: three quadrants. (D) Grade 4: four quadrants.

A small myringotomy was made radially on the anterior-inferior quadrant of the TM. Effusion in the middle ear was aspirated and a VT was placed into the TM. The characteristics of the effusion and presence of intraoperative bleeding were determined intraoperatively. For all patients, silicone VTs (Paparella Type; Medtronic Xomed, Minneapolis, MN, USA) were used; there were two types of VTs: type 1 had an internal diameter of 1.14 mm and type 2 had an internal diameter of 1.52 mm. The duration of effusion was defined as the time from initial detection of middle ear effusion to the time of surgery; duration of VT placement was defined from VTI to the extrusion of the VT from the TM whether the myringosclerosis was formed before or after tube extrusion. If the perforation of the TM continued for more than 3 months after removal of the tube, it was regarded as post-VTI perforation.

Statistical analysis

Statistical analysis was performed using SPSS for Windows, version 22 (SPSS Inc., Chicago, IL, USA). Independent t-tests were used for comparisons of age, frequency of VTI, duration of effusion, and duration of VT placement between the MS+ and MS− groups. The chi-squared test was used for comparisons between the two groups with regard to gender, characteristics of effusion, tube type, post-VTI infection, intraoperative bleeding, and post-VTI perforation. In addition, 1-way analysis of variance was performed to analyze the associations between severity of myringosclerosis and potential risk factors, including the frequency of VTI, duration of OME, and duration of VT placement. Post hoc analysis was performed using Tukey's test to assess potential factors affecting the severity of myringosclerosis development. In all analyses, P < 0.05 was considered to indicate statistical significance.

Ethics statement

The study protocol was approved by the Institutional Review Board (IRB) of Chungnam National University Hospital (IRB No. 2016-09-021) and the study was performed according to the approved protocol.

RESULTS

A total of 582 patients underwent VTI (men:women = 308:274). The patients ranged in age from 0 to 88 years, with a mean ± standard deviation (SD) age of 35.6 ± 27.8 years. Of these 582 patients, 168 (28.9%) had myringosclerosis (MS+ group) and 414 (71.1%) did not have myringosclerosis (MS− group). The mean ± SD age of the MS+ group was 39.84 ± 26.17 years, while that of the MS− group was 33.84 ± 28.29 years (P < 0.05) (Table 1). VTI was performed most commonly in patients 0–9 years old (190 patients, 32.65%) followed by patients 50–59 years old (90 patients, 15.46%); distinct myringosclerosis formation rates were observed in each age group (Fig. 2). Patients in this study who were < 6 years old had a lower rate of myringosclerosis formation than patients ≥ 6 years old (P < 0.05) (Fig. 3).

Table 1

Analysis of possible risk factors of myringosclerosis after ventilation tube insertion

Risk factors		MS+ group	MS− group	P value
Mean age, yr^a		39.84 ± 26.17	33.84 ± 28.29	< 0.05
Gender				0.727
	Men	87	221
	Women	81	193
Type of effusion				< 0.05
	Mucoid	29	143
	Serous^a	139	271
Duration of effusion, mon		3.17 ± 5.43	2.61 ± 2.79	0.200
Intra-VTI bleeding				0.929
	Bleeding−	160	395
	Bleeding+	8	19
Post-VTI infection				0.808
	Infection−	156	382
	Infection+	12	32
Post-VTI perforation				< 0.05
	Perforation−	154	406
	Perforation+^a	14	8
VT type				< 0.05
	Type 1	144	388
	Type 2^a	24	26
Duration of VT placement, mon		8.41 ± 5.17	7.86 ± 5.07	0.241
Frequency of VTI^a		1.71 ± 1.16	1.42 ± 0.99	< 0.05

Values are expressed as mean ± standard deviations or number.

MS+ = with myringosclerosis, MS− = without myringosclerosis, VTI = ventilation tube insertion, VT = ventilation tube.

^aStatistically significant risk factors, P < 0.05.

Fig. 2

Myringosclerosis formation after ventilation tube insertion, stratified according to age group.

MS+ = with myringosclerosis, MS− = without myringosclerosis.

Fig. 3

Comparison of myringosclerosis formation after ventilation tube insertion, stratified according to age (threshold at 6 years old).

MS+ = with myringosclerosis, MS− = without myringosclerosis.

Myringosclerosis was observed in 87 of 308 men patients (28.25%) and in 81 of 274 women patients (29.56%); thus, there was no significant gender-related difference in the incidence of myringosclerosis. With regard to possible risk factors, serous effusion, type 2 VT, post-VTI perforation, and frequent VTIs were associated with the formation of myringosclerosis after VTI (P < 0.05). Post-VTI infection, intraoperative bleeding, duration of effusion, and duration of VT placement were not significantly related to myringosclerosis formation (Table 1). A logistic regression analysis was performed to examine the association of explanatory variables: serous effusion, type 2 VT, post-VTI perforation, and frequent VTIs, further confirming the significance of each variable in the formation of myringosclerosis (P < 0.01, P = 0.028, 0.002, 0.002 respectively).

Among the possible risk factors for myringosclerosis formation, the duration of effusion and frequency of VTI were related to the severity of myringosclerosis. The duration of effusion was longer in the grade 3 and 4 group than in the grade 0 group, while the frequency of VTI was higher in the grade 1 and 2 group than in the grade 0 group (P < 0.05) (Fig. 4).

Fig. 4

Association between myringosclerosis severity after VTI depending on characteristics of ventilation tube insertion.

VT = ventilation tube, VTI = ventilation tube insertion.

^*P < 0.05.

DISCUSSION

In the present study, the rate of myringosclerosis formation after VTI was 28.9%, which was consistent with the findings of previous reports (32% and 35%).11 12 VTI related to OME was most commonly performed in patients 0–9 years old, followed by patients 50–59 years old; these increased incidences may be related to dysfunction of the immature Eustachian tube and OME induced by aging of the Eustachian tube, respectively. These findings were supported by the results of previous studies regarding changes in the Eustachian tube lumen and cartilage calcification with age.13 14 However, the incidence of myringosclerosis after VTI was highest among patients 20–29 years (68.2%) and lowest among patients 0–9 years (17.9%), although it was difficult to identify a clear statistical tendency due to differences in the numbers of patients in each group. According to a prior study of 126 school children who were 5–12 years old, the incidence of OME was much lower in children aged ≥ 6 years.15 The opening function of the Eustachian tube has been reported to improve significantly with age, and improvement is most common in pre-school age patients (3–7 years old).16 Thus, maturation of the structure (length) and function (active opening mechanism) of the Eustachian tube and maturation of the immune system by the age of 6 years could be associated with the observed reduction in the incidence of otitis media.17 When patients in the present study were stratified based on the age threshold of 6 years, the incidence of myringosclerosis formation after VTI was found to be higher in the group ≥ 6 years old than in the group < 6 years old. Our findings suggested that the degree of Eustachian tube maturation may be related to the formation of myringosclerosis and the occurrence of OME, although further studies are needed to confirm this hypothesis.

Various classification methods have been proposed based on histology or morphology of myringosclerosis, and most are related to the process by which myringosclerosis develops.3 Selcuk et al.3 classified myringosclerosis into three types based on the maturation of tympanosclerosis plaque: type I is characterized by fibroblasts, calcium crystals, and loose connective tissue under microscopic examination; these “pearl” tissues can be easily removed. Type II is characterized by calcification foci and large bundles of collagen, while type III is characterized by diffuse calcification and chondroblast-like cells. These histological findings show the sequence of myringosclerosis maturation. Akyildiz18 divided tympanosclerotic plaque into two types based on surgical detachment features: type 1 plaque is soft and easily removable with some calcium accumulation; in contrast, type 2 plaque is hard, white, fragile, and cannot be easily removed from peripheral tissues. However, these previously proposed classification systems require biopsy, which causes difficulty in preoperative evaluation of myringosclerosis. In the present study, we classified myringosclerosis based on severity in the TM.

The pathogenesis of myringosclerosis has not been fully elucidated. Mattsson et al.19 reported that free oxygen radicals generated by hyperoxic conditions in the middle ear resulted in the accumulation of sclerotic deposits. Karlidağ et al.20 reported that lower concentrations of antioxidants may increase the damage created by free oxygen radicals, providing an environment more favorable for the formation of myringosclerosis. Healed inflammation or scar tissue after recurrent inflammation have also been suggested as possible factors underlying the pathogenesis of myringosclerosis.8 21 There is no established treatment for myringosclerosis; however, some studies have demonstrated that the formation of myringosclerosis could be reduced by using antioxidants to reduce free radicals, as well as by applying topical vitamin E, N-acetylcysteine, sodium thiosulfate, and ciprofloxacin.2 5 19 22 23 24 Erdurak et al.25 reported that VTI with radiofrequency myringotomy, instead of incisional myringotomy with a cold knife, could reduce the formation of myringosclerosis.

Chronic inflammation of the middle ear and trauma to the TM are regarded as the most important factors related to the formation of myringosclerosis; however, other factors have not been investigated in detail.9 Yaman et al.7 reported that age was not a significant factor associated with the formation of myringosclerosis, although it was identified as a risk factor for the formation of myringosclerosis in this study. Although results vary among studies, the majority of studies (including the present study) have indicated that gender is not a risk factor for myringosclerosis formation.7 11 26 The duration of VT placement was considered to be an important factor in our study and in previous studies.7 11

Other risk factors have been analyzed in previous studies. Patients with a greater number of otitis episodes in the past year and those with a greater number of otorrhea episodes in the past year had higher rates of myringosclerosis after VTI.11 In addition, the anterior-inferior quadrant was identified as the highest risk quadrant for myringosclerosis formation, compared to the posterior-inferior quadrant, as a site of myringotomy.11 Yaman et al.7 reported that myringosclerosis was more likely to develop after VTI than after myringotomy alone. Koc and Uneri27 reported a higher rate of tympanosclerosis in patients with atherosclerosis, in comparison to the normal population; this result suggested that a genetic predisposition may be an additional risk factor for myringosclerosis formation. In the present study, the severity of myringosclerosis formation after VTI was related to the duration of effusion and frequency of VTI. Longer duration of effusion could result in a longer exposure time to middle ear inflammation, which may lead to more severe myringosclerosis formation.

There were some limitations in our study. Due to the retrospective nature of the study and the range of factors related to the formation of myringosclerosis, confounding factors may not have been effectively controlled, thereby reducing the impact of the findings.

This study identified the following risk factors for the formation of myringosclerosis after VTI: older age at onset, nature of middle ear effusion, post-VTI perforation, type 2 VT, and frequent VTI. A longer duration of effusion and more frequent VTI were associated with increased myringosclerosis severity. These risk factors for myringosclerosis formation may be useful in prediction of myringosclerosis before VTI, as well as in prevention after the procedure.

Notes

Funding: This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) (NRF-2018R1A2B2005022 and 2019M3E5D1A02068573).

Disclosure: The authors have no potential conflicts of interest to disclose.

Author Contributions:

Conceptualization: Park YH.
Data curation: Lee SH.
Formal analysis: Kim EH, Park KW, Kim BJ, Park YH.
Funding acquisition: Park YH.
Investigation: Kim BJ, Park YH.
Methodology: Kim EH, Lee SH.
Resources: Park YH.
Software: Park KW.
Supervision: Park YH.
Validation: Kim BJ, Park YH.
Visualization: Park KW, Lee SH.
Writing - original draft: Kim EH, Kim BJ.
Writing - review & editing: Kim BJ, Park YH.

References

1. El-Anwar MW, El-Aassar AS, El-Sayed H. Myringosclerosis in children with chronic renal failure on regular hemodialysis. Indian J Otol. 2015; 21(4):238–242.

2. Ozcan C, Görür K, Cinel L, Talas DU, Unal M, Cinel I. The inhibitory effect of topical N-acetylcysteine application on myringosclerosis in perforated rat tympanic membrane. Int J Pediatr Otorhinolaryngol. 2002; 63(3):179–184. PMID: 11997152.

3. Selcuk A, Ensari S, Sargin AK, Can B, Dere H. Histopathological classification of tympanosclerotic plaques. Eur Arch Otorhinolaryngol. 2008; 265(4):409–413. PMID: 17962967.

4. Gibb AG, Pang YT. Current considerations in the etiology and diagnosis of tympanosclerosis. Eur Arch Otorhinolaryngol. 1994; 251(8):439–451. PMID: 7718216.

5. Uneri C, Bağlam T, Yazici M. The effect of vitamin E treatment on the development of myringosclerosis after ventilation tube insertion. Int J Pediatr Otorhinolaryngol. 2006; 70(6):1045–1048. PMID: 16368152.

6. Khodaverdi M, Jørgensen G, Lange T, Stangerup SE, Drozdziewizc D, Tos M, et al. Hearing 25 years after surgical treatment of otitis media with effusion in early childhood. Int J Pediatr Otorhinolaryngol. 2013; 77(2):241–247. PMID: 23218983.

7. Yaman H, Guclu E, Yilmaz S, Ozturk O. Myringosclerosis after tympanostomy tube insertion: relation with tube retention time and gender. Auris Nasus Larynx. 2010; 37(6):676–679. PMID: 20392579.

8. Asiri S, Hasham A, al Anazy F, Zakzouk S, Banjar A. Tympanosclerosis: review of literature and incidence among patients with middle-ear infection. J Laryngol Otol. 1999; 113(12):1076–1080. PMID: 10767919.

9. Bhaya MH, Schachern PA, Morizono T, Paparella MM. Pathogenesis of tympanosclerosis. Otolaryngol Head Neck Surg. 1993; 109(3 Pt 1):413–420. PMID: 8414556.

10. Kim BJ, Kim J, Park IY, Jung JY, Suh MW, Oh SH. Effects of transient auditory deprivation during critical periods on the development of auditory temporal processing. Int J Pediatr Otorhinolaryngol. 2018; 104:66–71. PMID: 29287884.

11. Branco C, Monteiro D, Paço J. Predictive factors for the appearance of myringosclerosis after myringotomy with ventilation tube placement: randomized study. Eur Arch Otorhinolaryngol. 2017; 274(1):79–84. PMID: 27395069.

12. Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg. 2001; 124(4):374–380. PMID: 11283489.

13. Luntz M, Sadé J. Growth of the eustachian tube lumen with age. Am J Otolaryngol. 1988; 9(5):195–198. PMID: 3228177.

14. Takasaki K, Sando I, Balaban CD, Haginomori S, Ishijima K, Kitagawa M. Histopathological changes of the eustachian tube cartilage and the tensor veli palatini muscle with aging. Laryngoscope. 1999; 109(10):1679–1683. PMID: 10522942.

15. In : Casselbrant ML, Brostoff LM, Cantekin EI, Ashoff VM, Bluestone CD, editors. Otitis media in children in the United States. Proceedings of the International Conference on Acute and Secretory Otitis Media; 1985 Nov 17-22; Jerusalem, Israel. Amsterdam: Kugler Publication;1986. p. 161–164.

16. Bylander A, Tjernström O. Changes in Eustachian tube function with age in children with normal ears. A longitudinal study. Acta Otolaryngol. 1983; 96(5-6):467–477. PMID: 6637457.

17. Bluestone CD. Eustachian Tube: Structure, Function, and Role in Otitis Media. Hamilton: BC Decker Inc.;2005.

18. Akyıldız N. Kulak hastalıkları ve mikrocerrahisi. In : Akyıldız N, editor. Kulak Hastalıkları ve Mikrocerrahisi 1. Ankara: Bilimsel Tıp Yayınevi;1998. p. 461–472.

19. Mattsson C, Marklund SL, Hellström S. Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol. 1997; 106(6):513–518. PMID: 9199613.

20. Karlidağ T, Ilhan N, Kaygusuz I, Keleş E, Yalçin S. Comparison of free radicals and antioxidant enzymes in chronic otitis media with and without tympanosclerosis. Laryngoscope. 2004; 114(1):85–89. PMID: 14710000.

21. Branco C, Paço J. Does calcemia influence the onset of myringosclerosis after myringotomy with the insertion of ventilation tubes? Acta Otorrinolaringol Esp. 2017; 68(6):323–327. PMID: 28522133.

22. Park YH, Park CH, Kim HJ. The effect of topical sodium thiosulfate in experimentally induced myringosclerosis. Laryngoscope. 2010; 120(7):1405–1410. PMID: 20583241.

23. Akdagli S, Tuzuner A, Demirci S, Karadas H, Tulaci KG, Dogan M, et al. Do all antioxidant supplements have the same potential effect on preventing myringosclerosis? Clin Exp Otorhinolaryngol. 2015; 8(1):1–6. PMID: 25729488.

24. Arslan N, Tepe D, Taştan E, Demirci M, Caydere M, Ustun H, et al. Evaluation of the effectiveness of topical ciprofloxacin and prednisolone in the prevention of myringosclerosis. Eur Arch Otorhinolaryngol. 2012; 269(11):2335–2341. PMID: 22197890.

25. Erdurak SC, Coskun BU, Sakalli E, Tansuker HD, Turan F, Kaya D. Does the use of radiofrequency myringotomy for insertion of a ventilation tube reduce the incidence of myringosclerosis? Eur Arch Otorhinolaryngol. 2014; 271(3):459–462. PMID: 23494285.

26. Koc A, Uneri C. Sex distribution in children with tympanosclerosis after insertion of a tympanostomy tube. Eur Arch Otorhinolaryngol. 2001; 258(1):16–19. PMID: 11271428.

27. Koç A, Uneri C. Genetic predisposition for tympanosclerotic degeneration. Eur Arch Otorhinolaryngol. 2002; 259(4):180–183. PMID: 12064505.

TOOLS

Similar articles